Kircik L, Tsianakas A, Valenzuela F, Mikol V, et al. Efficacy and Safety of Rilzabrutinib in Patients With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Proof-of-Concept Phase II Clinical Trial. Br J Dermatol 2025 May 3:ljaf156. doi: 10.1093.
PMID: 40317187